Argos Therapeutics Inc (NASDAQ:ARGS) – Stock analysts at FBR & Co. raised their FY2015 earnings per share estimates for shares of Argos Therapeutics in a research note issued to investors on Tuesday, Zacks Investment Research reports. FBR & Co. analyst E. White now forecasts that the firm will post earnings of ($3.62) per share for […]
